2022-11-08T15:43:44-06:00 2022-07-31 010702717 PITTMAN & COMPANY LLP 8525 DOUGLAS AVE DES MOINES IA 50322 990 2021-08-01 421104334 IOWA ONCOLOGY RESEARCH ASSOCIATION IOWA 5152447586 1221 PLEASANT ST 450 DES MOINES IA 50309 JOSHUA LUKENBILL MD PRESIDENT/PRINCIPAL INVESTIGATOR 5152447586 2022-11-07 1 JOSHUA LUKENBILL MD XXX-XX-XXXX JOHN PITTMAN CPA P00288858 5152762727 2022-11-07 X 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z JOSHUA LUKENBILL MD 1221 PLEASANT ST 450 DES MOINES IA 50309 1300527 0 X WWW.IORA.ORG X 1978 IA TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA. THE ORGANIZATION IS FOUNDED ON THE PREMISES THAT HIGH QUALITY CLINICAL CANCER TREATMENT, CANCER CARE DELIVERY RESEARCH, AND CANCER CONTROL RESEARCH CAN BE CONDUCTED IN THE COMMUNITY BY ONCOLOGY PHYSICIANS, ONCOLOGY NURSE SPECIALISTS, CLINICAL RESEARCH ASSOCIATES, AND THAT THE COMMUNITY VENUE PROVIDES THE ULTIMATE PROVING GROUND FOR APPLICABILITY AND GENERALIZABILITY OF NEW CANCER TREATMENTS AND PREVENTION STRATEGIES FOR THE GENERAL POPULATION. 11 11 9 0 0 0 1242159 1239669 190942 6437 2 2 41274 54419 1474377 1300527 0 0 0 0 696683 801207 0 0 0 668047 664048 1364730 1465255 109647 -164728 821521 652663 67489 63359 754032 589304 TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA. 0 0 1304910 60856 ONCOLOGY RESEARCH 1304910 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 9 0 0 0 0 0 0 0 0 0 0 0 X 11 11 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 1 0 0 IA X THE ORGANIZATION 5152447586 1221 PLEASANT ST 450 DES MOINES IA 50309 X JOSHUA LUKENBILL PRESIDENT 5.00 X X 0 0 0 DEBORAH WILBUR MD VICE-PRESIDENT 5.00 X X 0 0 0 WENDY WOODS-SWAFFORD MD TREASURER 5.00 X X 0 0 0 DEBRA PROW SECRETARY 5.00 X X 0 0 0 WILLIAM FUSSELMAN MD MEMBER-AT-LARGE 1.00 X 0 0 0 ROBERT BEHRENS MEMBER-AT-LARGE 1.00 X 0 0 0 MICHAEL MARQUARDT MEMBER-AT-LARGE 1.00 X 0 0 0 NICK LOUDAS MEMBER-AT-LARGE 1.00 X 0 0 0 KATY JUHL PHARMD MEMBER-AT-LARGE 1.00 X 0 0 0 ARSHIN SHEYBANI MEMBER-AT-LARGE 1.00 X 0 0 0 SEEMA HARICHAND MEMBER-AT-LARGE 1.00 X 0 0 0 0 0 0 0 0 0 0 0 1600 1225688 12381 11614 1239669 PHARMACEUTICAL STUDIES 900099 23997 23997 ANCILLARY FUNDS 900099 -17560 -17560 6437 2 2 WAGE REIMBURSEMENT 900099 52317 52317 MISCELLANEOUS 900099 2102 2102 54419 1300527 60856 0 2 105214 105214 558617 508211 50406 85285 85285 52091 52091 48663 14948 33715 5870 5870 32846 32846 760 760 2000 2000 15599 15599 7535 7535 SUBRECIPIENTS 520059 520059 DUES & SUBSCRIPTIONS 18698 18698 IN-KIND 11614 11614 PHARMA STUDIES 320 320 84 84 1465255 1304910 160345 0 612622 479499 3566 3568 48335 19413 24449 214063 68916 125085 145147 12500 0 821521 652663 67489 63359 67489 63359 X 754032 589304 754032 589304 821521 652663 -164728 0 X 0 1 X 1 1 1 X IOWA METHODIST MEDICAL CENTER DES MOINES IA 102650 18249 84401 111413 50667 60746 145147 FORM 990, PART VI, SECTION B, LINE 11B A DRAFT OF THE FORM 990 WAS PROVIDED TO THE BOARD OF DIRECTORS FOR REVIEW PRIOR TO BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST FORMS ARE REVIEWED BY THE UNITY POINT INSTITUTIONAL REVIEW BOARD (IRB). IF ANY CONFLICTS ARE FOUND, THE IRB COMMUNICATES THOSE TO THE ORGANIZATION AND DEFINES ANY LIMITATIONS IN PARTICIPATING IN RESEARCH. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS EVALUATES SALARY SURVEYS FROM THE NATIONAL CANCER INSTITUTE AND SOCIETY OF CLINICAL RESEARCH ASSOCIATES. THESE SURVEYS ARE USED IN CONJUCTION WITH PERFORMANCE DATA TO DETERMINE EXECUTIVE DIRECTOR COMPENSATION. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FINANCIAL STATEMENTS AND OTHER GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST.